MedPath

Smartphone-based intervention for reducing postpartum depressive symptoms (Smart-e-Moms): Randomized controlled trial

Not Applicable
Conditions
Postpartum depressive symptoms
F53.0
Mild mental and behavioural disorders associated with the puerperium, not elsewhere classified
Registration Number
DRKS00032324
Lead Sponsor
Freie Universität Berlin
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Female
Target Recruitment
556
Inclusion Criteria

Women between 6 weeks and 6 months after delivery with an elevated score of postpartum depressive symptomatology (EPDS = 10, cutoff for clinically relevant depressive symptoms)

Exclusion Criteria

Acute psychotic symptoms or acute suicidality. Current Psychotherapy.

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Postpartum depressive symptoms, measured by the Edinburgh Postpartum Depression Scale (EPDS), at 6 weeks, 12 weeks and 24 weeks after allocation
Secondary Outcome Measures
NameTimeMethod
Secondary outcomes are: <br>1) Parental Bonding Questionnaire (PBQ-16, Reck et al., 2006)<br>2) General Self-Efficacy Scale (GSE, Jerusalem & Schwarzer, 1999)<br>3) 1-Item Perkhofer Stress Scale (Buchberger et al., 2019)<br>4) System Usability Scale (SUS, Brooke et al., 1996)<br>5) Client Satisfaction Questionnaire (CSQ-I, Boß et al., 2016)<br>6) An IBI-adapted version of the 12-item Working Alliance Inventory (WAI-SR, Berger, 2017) to assess the therapeutic alliance<br>7) Health care utilization will be asssesses with selected adapted items of the FIMPsy (Grupp, 2017)<br>8) Birth-related PTSD will be assessed with the City Birth Trauma Scale (City BiTS, Ayers, Wright & Thornton, 2018). <br>9) Patient Questionnaire on Therapy Expectation and Evaluation (PATHEV, Schulte, 2006) <br>10) Childhood Trauma Screener (CTS, Grabe, 2012) <br>11) Sociodemographic, clinical and pregnancy-related variables will be assessed as potential moderators
© Copyright 2025. All Rights Reserved by MedPath